These 10 Stocks Led Rally on Wednesday

8. Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)

Recursion Pharmaceuticals extended its winning streak for a fourth consecutive day, adding another 8.88 percent to its valuation to finish Wednesday at $8.34 apiece as investors continued to place bets on the company ahead of the release of its earnings performance in the next few weeks.

In the third quarter of 2024, RXRX widened its net loss by 3 percent to $95.8 million from the $93 million registered in the same period last year, despite revenues soaring by 148 percent to $26.1 million from $10.5 million year-on-year.

RXRX is a clinical-stage biotechnology company leading the space by decoding biology to industrialize drug discovery.

RXRX leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias.